Products
Explore our advanced sequencing products for turning complex molecular signals into high-confidence readouts across clinical testing, RNA quality control, and translational methylation programs.




Renew’s Telomere Sequencing supports studies requiring detailed characterization of telomere length and chromosome-end biology, including studies of aging and longevity, oncology, and biomarker discovery.
Renew uses native long-read sequencing to measure telomere length while preserving subtelomeric context and native epigenetic modifications. Unlike methods focused primarily on global or population-level telomere measurements, the workflow provides chromosome arm-specific telomere length alongside subtelomeric methylation and structural information from extracted DNA.
The assay measures global and chromosome arm-specific telomere length, short telomeres, and telomere length heterogeneity. It also supports analysis of subtelomeric methylation, differentially methylated regions (DMRs), structural variants, and adjacent genomic context.
Yes. Renew’s workflow provides chromosome arm-specific telomere length measurements, enabling characterization of individual chromosome ends in addition to global telomere length and telomere length heterogeneity.
Standard deliverables include telomere length measurements, chromosome arm-specific results, sequencing QC metrics, and sequencing data. Subtelomeric methylation, structural variant, and other project-specific analyses can be incorporated based on study objectives.
Telomere Sequencing is compatible with high-molecular-weight genomic DNA from human and other eukaryotic organisms, including DNA derived from fresh, frozen, cultured, and biobanked samples. Project-specific input requirements are provided during study planning.
Yes. Renew provides experimental design consultation, bioinformatics support, QC review, and post-project technical consultation. Custom analyses can be developed around telomere length, subtelomeric methylation, structural variation, and other chromosome-end features based on study objectives.